Chromosomally encoded ß-lactamases from the Burkholderia cepacia complex species (formerly Pseudomonas cepacia) were characterized. Cloning and sequencing identified an Ambler class A ß-lactamase (PenB) from B. cenocepacia. It shares 82% amino acid identity with the PenA ß-lactamases previously identified from B. multivorans 249. Its expression was dependent upon a LysR-type regulatory protein. Its narrow-spectrum hydrolysis activity mostly included penicillins but also included expanded-spectrum cephalosporins and aztreonam at lower levels. In that study, Pen-like ß-lactamases (PenC, PenD, PenE, PenF) that shared 63 to 92% identity with PenB from B. cenocepacia were identified from other Burkholderia species. The corresponding ß-lactamase genes might be used as genetic tools for accurate Burkholderia species identification.Over the last two decades, Burkholderia cepacia (previously Pseudomonas cepacia) has been recognized as an ubiquitous and opportunistic pathogen of increasing importance, particularly in nosocomial infections in immunocompromised hosts and cystic fibrosis (CF) patients (20,30,32,35). The Burkholderia cepacia complex is divided into at least 10 different closely related species: B. cepacia, B. multivorans, B. cenocepacia, B. stabilis, B. vietnamiensis, B. dolosa, B. ambifaria, B. anthina, B. pyrrocinia, and B. ubonensis (genomovars I, II, III, IV, V, VI, VII, VIII, IX, and X, respectively) (21, 31, 40). Some epidemic clones have been described as sources of human infections in Canada, the United Kingdom, and France (12,14,15,16,33); and B. cepacia complex strains are also commonly found in the environment in soil (10, 18), water (39), and onions (6). The prevalence of isolation of Bulkholderia sp. strains in CF patients in France is about 3.1%, with B. cenocepacia (genomovar III) and B. multivorans (genomovar II) being the most frequently isolated bacterial species (3, 21).The treatment of B. cepacia infections is difficult, since B. cepacia species often have high-level intrinsic resistance to many antibiotics, including ticarcillin, most cephalosporins, aminoglycosides, fosfomycin, and the polymyxins (5, 41). However, Nzula et al. have noticed a heterogeneity of intrinsic antibiotic resistance patterns among the members of the B. cepacia complex that is likely related to the genomovar type (25).Resistance to -lactam antibiotics in isolates of the B. cepacia complex has been related to a chromosomal and inducible -lactamase which has been falsely identified as an AmpC enzyme (28). Then, Trépanier et al. (36) described a chromosomal Ambler class A -lactamase (PenA) from B. cepacia 249. The PenA ß-lactamase possesses a narrow-spectrum profile, and it is regulated by a LysR-type transcriptional regulator, PenR. This negative regulator is responsible for the inducibility of PenA expression (36).The aim of the study described here was to identify the putative ß-lactamases produced by strains belonging to the B. cepacia complex and, in particular, to characterize the ß-lactamase determinants ...